Signaling Pathways - Glutamate (Metabotropic) Group I Receptors - PD-1/PD-L1 interaction - MARK1 - Phosphodiesterases (PDEs)
清除全部
- B6023 PD-1/PD-L1 inhibitor 2Target: PD-1/PD-L1 interactionSummary: PD-1/PD-L1相互作用的抑制剂
- B5532 NPS 2390Target: Glutamate (Metabotropic) Group I ReceptorsSummary: I型mGlu拮抗剂
- B6988 BRL 50481Target: Phosphodiesterases (PDEs)Summary: PDE7抑制剂
- B6569 CHPGTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: mGlu5代谢型谷氨酸受体激动剂
- B6304 Etazolate hydrochloride2 CitationTarget: Phosphodiesterases (PDEs)Summary: PDE-4抑制剂和选择性GABA-A受体调节剂
- B3439 Udenafil中文名: 乌地那非Target: Phosphodiesterases (PDEs)Summary: PDE5抑制剂
- B1386 Milrinone中文名: 米力农Target: Phosphodiesterases (PDEs)Summary: PDE3抑制剂
- B2276 Vinpocetine中文名: 长春西汀Target: Phosphodiesterases (PDEs)Summary: PDE抑制剂
- A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂
- A3633 MPEP HydrochlorideTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: MGlu5受体拮抗剂